Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contrast Media | 9 | 2025 | 486 | 1.200 |
Why?
|
| Fluorocarbons | 2 | 2018 | 66 | 1.090 |
Why?
|
| Nanoparticles | 7 | 2025 | 292 | 0.980 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 869 | 0.960 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2024 | 3833 | 0.760 |
Why?
|
| Plaque, Amyloid | 3 | 2020 | 63 | 0.720 |
Why?
|
| Mouth Neoplasms | 1 | 2023 | 98 | 0.710 |
Why?
|
| Indans | 1 | 2021 | 53 | 0.700 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2018 | 60 | 0.700 |
Why?
|
| Liposomes | 6 | 2019 | 201 | 0.660 |
Why?
|
| alpha-Synuclein | 1 | 2021 | 140 | 0.650 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 161 | 0.640 |
Why?
|
| Fluorine | 1 | 2018 | 14 | 0.590 |
Why?
|
| Amyloid | 2 | 2020 | 74 | 0.570 |
Why?
|
| Papillomavirus Infections | 1 | 2023 | 392 | 0.560 |
Why?
|
| Fluorine-19 Magnetic Resonance Imaging | 1 | 2018 | 4 | 0.560 |
Why?
|
| Ethers | 1 | 2018 | 8 | 0.560 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2020 | 115 | 0.510 |
Why?
|
| Blood-Brain Barrier | 2 | 2014 | 147 | 0.490 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2014 | 12 | 0.440 |
Why?
|
| Presenilin-1 | 2 | 2020 | 52 | 0.430 |
Why?
|
| Cerebral Arteries | 1 | 2014 | 80 | 0.420 |
Why?
|
| Placenta | 3 | 2022 | 528 | 0.360 |
Why?
|
| Amyloid beta-Peptides | 1 | 2012 | 230 | 0.340 |
Why?
|
| Cyclohexanones | 1 | 2010 | 18 | 0.330 |
Why?
|
| Enterotoxins | 1 | 2009 | 77 | 0.300 |
Why?
|
| Small Molecule Libraries | 1 | 2010 | 135 | 0.290 |
Why?
|
| Cyclic GMP | 1 | 2009 | 90 | 0.290 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2022 | 147 | 0.280 |
Why?
|
| Bacterial Toxins | 1 | 2009 | 171 | 0.280 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 578 | 0.280 |
Why?
|
| Brain | 3 | 2024 | 3161 | 0.260 |
Why?
|
| Molecular Structure | 6 | 2021 | 320 | 0.240 |
Why?
|
| Mice | 11 | 2023 | 18410 | 0.240 |
Why?
|
| Drug Design | 2 | 2021 | 165 | 0.240 |
Why?
|
| Medical Marijuana | 1 | 2025 | 6 | 0.240 |
Why?
|
| Pyrimidines | 1 | 2009 | 437 | 0.240 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2025 | 2095 | 0.210 |
Why?
|
| Animals | 14 | 2025 | 34278 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 1625 | 0.200 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 2358 | 0.200 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 4681 | 0.200 |
Why?
|
| Ligands | 2 | 2021 | 485 | 0.190 |
Why?
|
| Indocyanine Green | 1 | 2023 | 54 | 0.190 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 157 | 0.180 |
Why?
|
| Fluorescent Dyes | 1 | 2023 | 251 | 0.180 |
Why?
|
| Protein Aggregates | 1 | 2021 | 43 | 0.170 |
Why?
|
| Triiodobenzoic Acids | 1 | 2021 | 30 | 0.170 |
Why?
|
| Protein Folding | 1 | 2021 | 215 | 0.170 |
Why?
|
| X-Ray Microtomography | 1 | 2021 | 100 | 0.160 |
Why?
|
| Global Health | 1 | 2025 | 631 | 0.160 |
Why?
|
| Aortography | 1 | 2021 | 158 | 0.160 |
Why?
|
| Aortic Rupture | 1 | 2021 | 114 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2021 | 214 | 0.150 |
Why?
|
| Esters | 2 | 2009 | 33 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 348 | 0.150 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 41 | 0.150 |
Why?
|
| Solubility | 1 | 2018 | 120 | 0.140 |
Why?
|
| Limit of Detection | 1 | 2018 | 74 | 0.140 |
Why?
|
| Integrin alpha4beta1 | 1 | 2018 | 26 | 0.140 |
Why?
|
| Aortic Aneurysm | 1 | 2021 | 229 | 0.140 |
Why?
|
| Phantoms, Imaging | 1 | 2018 | 144 | 0.140 |
Why?
|
| Aorta | 1 | 2021 | 534 | 0.130 |
Why?
|
| Polyethylene Glycols | 2 | 2012 | 245 | 0.110 |
Why?
|
| Atherosclerosis | 1 | 2022 | 943 | 0.100 |
Why?
|
| Phosphatidylethanolamines | 1 | 2012 | 23 | 0.100 |
Why?
|
| Protein Binding | 2 | 2018 | 1705 | 0.100 |
Why?
|
| Zingiberaceae | 2 | 2003 | 3 | 0.100 |
Why?
|
| Cobalt | 2 | 2009 | 16 | 0.100 |
Why?
|
| Organophosphorus Compounds | 2 | 2009 | 26 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2016 | 388 | 0.090 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 170 | 0.090 |
Why?
|
| Boronic Acids | 1 | 2012 | 49 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2012 | 117 | 0.090 |
Why?
|
| Humans | 9 | 2025 | 130931 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 211 | 0.080 |
Why?
|
| Hydrocarbons, Iodinated | 1 | 2010 | 2 | 0.080 |
Why?
|
| Quinones | 1 | 2010 | 4 | 0.080 |
Why?
|
| Esterification | 1 | 2010 | 13 | 0.080 |
Why?
|
| Cyclohexenes | 1 | 2010 | 11 | 0.080 |
Why?
|
| Methane | 1 | 2010 | 18 | 0.080 |
Why?
|
| Receptors, Enterotoxin | 1 | 2009 | 1 | 0.080 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 1 | 2009 | 1 | 0.080 |
Why?
|
| Guanylate Cyclase | 1 | 2009 | 33 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 465 | 0.080 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 112 | 0.070 |
Why?
|
| Receptors, Peptide | 1 | 2009 | 57 | 0.070 |
Why?
|
| Enterobacter aerogenes | 1 | 2008 | 2 | 0.070 |
Why?
|
| Gadolinium | 2 | 2019 | 110 | 0.070 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2008 | 70 | 0.070 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 53 | 0.070 |
Why?
|
| Hippocampus | 1 | 2012 | 794 | 0.070 |
Why?
|
| Insulin | 1 | 2012 | 1148 | 0.060 |
Why?
|
| Escherichia coli Proteins | 1 | 2009 | 310 | 0.060 |
Why?
|
| Plants, Medicinal | 2 | 2003 | 25 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 4738 | 0.060 |
Why?
|
| Cannabis | 1 | 2025 | 49 | 0.060 |
Why?
|
| Photons | 1 | 2025 | 56 | 0.050 |
Why?
|
| Pregnancy | 3 | 2022 | 7558 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2009 | 981 | 0.050 |
Why?
|
| Diarylheptanoids | 1 | 2003 | 1 | 0.050 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2003 | 19 | 0.050 |
Why?
|
| Trypanocidal Agents | 1 | 2003 | 33 | 0.050 |
Why?
|
| Vimentin | 1 | 2022 | 63 | 0.050 |
Why?
|
| Adventitia | 1 | 2022 | 5 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 31 | 0.050 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 294 | 0.050 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 3642 | 0.040 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 80 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2020 | 82 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2018 | 1084 | 0.040 |
Why?
|
| Angiotensin II | 1 | 2021 | 136 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2021 | 191 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2020 | 365 | 0.040 |
Why?
|
| tau Proteins | 1 | 2022 | 253 | 0.040 |
Why?
|
| Blood Volume | 1 | 2019 | 71 | 0.040 |
Why?
|
| Diet, High-Fat | 1 | 2021 | 262 | 0.040 |
Why?
|
| Hydrolysis | 2 | 2009 | 140 | 0.040 |
Why?
|
| Placentation | 1 | 2019 | 59 | 0.040 |
Why?
|
| Catalysis | 2 | 2008 | 136 | 0.040 |
Why?
|
| Female | 4 | 2022 | 70755 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 632 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2009 | 429 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2018 | 98 | 0.030 |
Why?
|
| Kinetics | 2 | 2009 | 1101 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 459 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2020 | 776 | 0.030 |
Why?
|
| Male | 3 | 2021 | 64823 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 2287 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1215 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2191 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 3457 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 3365 | 0.020 |
Why?
|
| Seeds | 2 | 2003 | 42 | 0.020 |
Why?
|
| Concanavalin A | 1 | 2012 | 14 | 0.020 |
Why?
|
| Dextrans | 1 | 2012 | 45 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2012 | 153 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 2012 | 88 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 117 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 332 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 277 | 0.020 |
Why?
|
| Time Factors | 1 | 2021 | 6275 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 694 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3850 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2012 | 442 | 0.020 |
Why?
|
| Cell Survival | 1 | 2012 | 850 | 0.020 |
Why?
|
| Potassium Compounds | 1 | 2008 | 7 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2008 | 16 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2008 | 79 | 0.020 |
Why?
|
| Magnetics | 1 | 2008 | 31 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1614 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 567 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 300 | 0.020 |
Why?
|
| Phosphates | 1 | 2008 | 110 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2008 | 285 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2008 | 365 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 586 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 853 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 1200 | 0.010 |
Why?
|
| Aged | 1 | 2024 | 21134 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 17485 | 0.010 |
Why?
|
| Cameroon | 1 | 2003 | 10 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2003 | 42 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 85 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 2003 | 116 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 281 | 0.010 |
Why?
|